Recently, SNAT1/2 (SLC38A1/2) have been implicated as important players in maintenance of cellular glutamine levels in the absence of ASCT2, thus broadening the role of glutamine transport in cancer cells and mTORC1 activity (36). Here, SLC38A1 is linked to cancer.